Your Best Stock

Moderna MRNA

US equityMarket cap rank #209Infectious Disease
$198.88
+$4.06 (+2.08%)
After hours · Sep 25, 7:10 pm ET
After hours $197.89 -0.50%
Open$195.35
Prev close$194.82
Day range$192.51 – $202.67
Volume13.91M
Market cap$79.40B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$143.00M+4.4% YoY
Operating profit-$815.00M+10.1% YoY
Net profit-$782.00M+5.2% YoY
Diluted EPS-$1.97+7.5% YoY
Free cash flow-$563.00M+38.9% YoY
Operating cash flow-$526.00M

Revenue, last 8 quarters

$1.9BSep '24$956.0MDec '24$107.0MMar '25$137.0MJun '25$1.0BSep '25$676.0MDec '25$389.0MMar '26$143.0MJun '26

Net profit, last 8 quarters

$13.0MSep '24$-1.1BDec '24$-971.0MMar '25$-825.0MJun '25$-200.0MSep '25$-826.0MDec '25$-1.3BMar '26$-782.0MJun '26

Diluted EPS by quarter

0.03Sep '24-2.91Dec '24-2.52Mar '25-2.13Jun '25-0.51Sep '25-2.11Dec '25-3.40Mar '26-1.97Jun '26

Free cash flow by quarter

$-1.7BSep '24$303.0MDec '24$-1.2BMar '25$-922.0MJun '25$-880.0MSep '25$891.0MDec '25$-692.0MMar '26$-563.0MJun '26

Annual revenue

$274.0MFY20$17.7BFY21$18.9BFY22$6.8BFY23$3.2BFY24$1.9BFY25

Profitability & balance sheet

Gross margin22.8%
Operating margin-150.2%
Net margin-142.6%
Return on equity-39.0%
Return on assets-27.4%
Return on invested capital-36.2%
Current ratio2.29
Liabilities / assets38.3%
Cash & investments$5.14B
Total debt$1.24B
Net cash (debt)$3.90B

Where the revenue comes from

Quarter 2026/Q2

By business line

  • COVID$91.00M 62.8%
  • Other revenue$51.00M 35.2%
  • Respiratory syncytial virus (RSV)$3.00M 2.1%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $145.00M $389.00M $1.94B $678.00M $1.02B
Total Operating Revenue $143.00M $389.00M $1.92B $676.00M $1.00B
Cost of Revenue $93.00M $955.00M $868.00M $452.00M $207.00M
Gross Profit $50.00M -$566.00M $1.05B $224.00M $795.00M
Operating Expense $865.00M $822.00M $4.13B $1.08B $1.06B
Selling and Admin Expenses $216.00M $173.00M $1.02B $308.00M $268.00M
Research & Development $651.00M $649.00M $3.13B $775.00M $801.00M
Other Operating Expenses -$2.00M – -$22.00M -$2.00M -$14.00M
Operating Profit -$815.00M -$1.39B -$3.07B -$857.00M -$260.00M
Net Non-Operating Interest Income (Expense) $50.00M $55.00M $304.00M $62.00M $73.00M
Non-Operating Interest Income $67.00M $72.00M $314.00M $70.00M $73.00M
Non-Operating Interest Expense $17.00M $17.00M $10.00M $8.00M $0.00
Other Income (Expense) -$2.00M -$1.00M $2.00M -$4.00M –
Other Non-Operating Income (Expenses) -$2.00M – $7.00M -$2.00M -$4.00M
Pretax Profit -$767.00M -$1.33B -$2.77B -$799.00M -$187.00M
Tax $15.00M $9.00M $54.00M $27.00M $13.00M
Net Profit -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
Profit from Continuing Operations -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
Net Income to Parent Company -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
Net Income to Common Stockholders -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
Basic EPS -$1.97 -$3.40 -$7.26 -$2.11 -$0.51
Diluted EPS -$1.97 -$3.40 -$7.26 -$2.11 -$0.51
Gain on Sale of Security – -$1.00M -$5.00M -$2.00M $4.00M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $10.96B $11.49B $12.34B $12.34B $12.14B
Total Current Assets $5.82B $5.77B $6.54B $6.54B $6.60B
Cash and Cash Equivalents & Short-Term Investments $5.14B $5.21B $5.80B $5.80B $4.50B
-Cash and Cash Equivalents $1.72B $1.91B $2.60B $2.60B $1.13B
-Short Term Investments $3.42B $3.30B $3.20B $3.20B $3.37B
Receivables $139.00M $182.00M $284.00M $284.00M $1.39B
-Accounts Receivable $17.00M $71.00M $184.00M $184.00M $1.05B
-Accrued Interest Receivable $40.00M $39.00M $42.00M $42.00M $40.00M
-Taxes Receivable $51.00M $64.00M $45.00M $45.00M $104.00M
-Other Receivables $31.00M $8.00M $13.00M $13.00M $204.00M
Prepaid Assets $216.00M $186.00M $263.00M $263.00M $312.00M
Inventory $280.00M $146.00M $153.00M $153.00M $332.00M
Other Current Assets $42.00M $51.00M $45.00M $45.00M $56.00M
Total Non-Current Assets $5.15B $5.72B $5.79B $5.79B $5.54B
Net PPE $2.76B $2.79B $2.85B $2.85B $2.86B
-Gross PPE $3.61B $3.59B $3.59B $3.59B $3.54B
-Accumulated Depreciation -$849.00M -$794.00M -$737.00M -$737.00M -$671.00M
Investments and Advances $1.77B $2.25B $2.34B $2.34B $2.15B
-Available for Sale Securities $1.77B $2.25B $2.34B $2.34B $2.14B
Non Current Accounts Receivables $161.00M $161.00M $161.00M $161.00M $99.00M
Non-Current Prepaid Assets $90.00M $97.00M $100.00M $100.00M $105.00M
Goodwill and Other Intangible Assets $161.00M $168.00M $97.00M $97.00M $99.00M
-Goodwill $52.00M $52.00M $52.00M $52.00M $52.00M
-Other Intangible Assets $109.00M $116.00M $45.00M $45.00M $47.00M
Non-Current Deferred Assets $82.00M $82.00M $81.00M $81.00M $81.00M
Other Non-Current Assets $124.00M $167.00M $160.00M $160.00M $137.00M
Total Liabilities $4.20B $4.08B $3.69B $3.69B $2.81B
Total Current Liabilities $2.53B $2.40B $1.99B $1.99B $1.68B
Payables $167.00M $161.00M $317.00M $317.00M $267.00M
-Accounts Payable $167.00M $161.00M $317.00M $317.00M $267.00M
Current Accrued Expenses $1.30B $1.33B $457.00M $457.00M $442.00M
Short-Term Debt and Capital Lease Obligation $52.00M $50.00M $42.00M $42.00M $48.00M
-Current Capital Lease Obligation $52.00M $50.00M $42.00M $42.00M $48.00M
Current Provisions $421.00M $470.00M $509.00M $509.00M $426.00M
Current Deferred Liabilities $295.00M $102.00M $99.00M $99.00M $163.00M
Other Current Liabilities $111.00M $170.00M $143.00M $143.00M $25.00M
Total Non-Current Liabilities $1.67B $1.69B $1.70B $1.70B $1.12B
Long Term Accounts Payable and Other Payables $255.00M $253.00M $249.00M $249.00M $239.00M
Long Term Debt and Capital Lease Obligation $1.24B $1.25B $1.26B $1.26B $686.00M
-Long Term Debt $591.00M $590.00M $590.00M $590.00M –
-Long Term Capital Lease Obligation $644.00M $658.00M $673.00M $673.00M $686.00M
Non-Current Deferred Liabilities $147.00M $154.00M $153.00M $153.00M $157.00M
Other Non-Current Liabilities $29.00M $30.00M $36.00M $36.00M $42.00M
Total Equity $6.76B $7.41B $8.65B $8.65B $9.33B
Stockholders' Equity $6.76B $7.41B $8.65B $8.65B $9.33B
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.64B $1.50B $1.38B $1.38B $1.25B
Retained Earnings $5.10B $5.88B $7.22B $7.22B $8.05B
Gains/Losses Not Affecting Retained Earnings $19.00M $25.00M $45.00M $45.00M $27.00M
-Long Term Equity Investment – – $6.00M $6.00M $9.00M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$526.00M -$630.00M -$1.87B $930.00M -$847.00M
Net cash flow from continuing operations -$526.00M -$630.00M -$1.87B $930.00M -$847.00M
Net Income from Continuing Operations -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
Gain/Loss from Continuing Operations $0.00 $2.00M $8.00M $3.00M -$3.00M
Depreciation & Depletion & Amortization $63.00M $59.00M $215.00M $67.00M $52.00M
Other Non-Cash Items $4.00M $6.00M $77.00M $27.00M $14.00M
Change in Working Capital $79.00M $553.00M $233.00M $1.56B -$818.00M
-Change in Receivables $53.00M $114.00M $156.00M $859.00M -$1.01B
-Change in Inventory -$132.00M $6.00M -$34.00M $179.00M -$91.00M
-Change in Prepaid Assets $16.00M $54.00M $153.00M $237.00M $66.00M
-Change in Payables and Accrued Expense $3.00M $344.00M -$94.00M $216.00M $288.00M
-Change in Other Current Assets $10.00M $11.00M $38.00M $10.00M $9.00M
-Change in Other Current Liabilities -$61.00M $19.00M -$27.00M $125.00M -$117.00M
-Change In Other Working Capital $190.00M $5.00M $41.00M -$67.00M $40.00M
Net cash flow from investing $329.00M -$76.00M $1.95B -$48.00M $700.00M
Net Cash Flow from Continuing Investing Activities $329.00M -$76.00M $1.95B -$48.00M $700.00M
Net PPE Purchase and Sale -$37.00M -$62.00M -$192.00M -$39.00M -$33.00M
Net Intangibles Purchase and Sale $0.00 $0.00 -$10.00M $0.00 $0.00
Net Investment Purchase and Sale $366.00M -$14.00M $2.15B -$9.00M $733.00M
Financing Cash Flow $14.00M $17.00M $593.00M $581.00M -$1.00M
Net Cash Flow from Continuing Financing Activities $14.00M $17.00M $593.00M $581.00M -$1.00M
Net Issuance Payments Of Debt -$7.00M $0.00 $560.00M $566.00M -$3.00M
Net Common Stock Issuance $23.00M $19.00M $35.00M $16.00M $2.00M
Net Other Financing Charges -$2.00M -$2.00M -$2.00M -$1.00M $0.00
Ending Cash Balance $1.72B $1.91B $2.60B $2.60B $1.13B
Net Change in Cash -$183.00M -$689.00M $666.00M $1.46B -$148.00M
Beginning Cash Balance $1.91B $2.60B $1.93B $1.13B $1.28B
Effect of Exchange Rate Changes -$2.00M $1.00M $2.00M $0.00 $1.00M
Free Cash Flow -$563.00M -$692.00M -$2.08B $891.00M -$880.00M
Net Business Purchase and Sale – – $0.00 – –
Scroll to Top